Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

This study is testing whether a new drug called TQB2825 works better than standard immunotherapy for people with follicular lymphoma that has returned or hasn't responded to previous treatments. The trial will involve 228 adults who have already tried at least two other treatment…

This study is testing whether a new drug combination works better than standard treatment for advanced stomach or gastroesophageal junction cancer. It is for adults with a specific tumor marker (CLDN18.2) who have not yet received treatment for their advanced cancer. The goal is …

This study aims to test the safety and effectiveness of an investigational injection called TQH2722 for people with seasonal allergic rhinitis (hay fever). About 300 adults with significant seasonal allergy symptoms will receive the injection along with their usual background all…